David D. Chang

Holdings History for Allogene Therapeutics, Inc. - Common Stock (ALLO)

Symbol: ALLO on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Shares Owned: 12,101,223 shares
Security Ownership %: 5.2%

David D. Chang, M.D., Ph.D. ownership in Allogene Therapeutics, Inc. Common Stock (ALLO)

13 Feb 2026 - David D. Chang, M.D., Ph.D. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 12,101,223 shares of Allogene Therapeutics, Inc. Common Stock (ALLO). This represents 5.2% ownership of the company. In their previous filing dated 12 Nov 2025, David D. Chang had reported owning 11,234,918 shares, indicating an increase of +7.7%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
David D. Chang, M.D., Ph.D.	5.2%	+6%	$16,578,676	12,101,223	+866,305	+7.7%	$1.37	13G	31 Dec 2025	13 Feb 2026, 16:22
David D. Chang, M.D., Ph.D.	4.9%	-2%	$13,931,298	11,234,918	+98,190	+0.88%	$1.24	13G/A	30 Sep 2025	12 Nov 2025, 16:37
David D. Chang, M.D., Ph.D.	5%	0%	$14,255,012	11,136,728	+93,628	+0.85%	$1.28	13G/A	30 Jun 2025	08 Aug 2025, 20:13
David D. Chang, M.D., Ph.D.	5%	-2%	$17,006,374	11,043,100	+138,097	+1.3%	$1.54	13G/A	31 Mar 2025	09 May 2025, 17:49
David D. Chang, M.D., Ph.D.	5.1%		$16,793,705	10,905,003			$1.54	13G/A	31 Dec 2024	13 Feb 2025, 16:29